Impact of Erythropoietin Administration During Definitive Cervix Cancer Radiotherapy on Treatment Outcome
Status:
Unknown status
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether an increase of blood haemoglobin levels
through the substitution of erythropoietin during radiotherapy treatment of cervix cancer
patients results in improvement for disease specific survival, tumor response and local
control.